Home › Biotech with unproven Alzheimer's drug now worth billions
 

Keywords :   


Biotech with unproven Alzheimer's drug now worth billions

2015-06-12 08:42:22| Biotech - Topix.net

Investors are giving Axovant Sciences Ltd. an almost $3 billion valuation after its public-market debut.

Tags: worth drug biotech billions

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.11Costume
24.11BB S604ULS
24.1133
24.11 ElectronicAudioExperimentsDude Incedible
24.11 TC101 5IP 6 NS.NEO 950GH S
24.11
24.11
24.11
More »